In a 1988 paper summarizing his findings, Fiebig concluded that xenograft mice were wonderful models for broadly testing new drugs against human tumors, but they «can not be used as
a clinical routine method» for predicting patient treatment.1 The idea of using xenograft mice as personal avatars for cancer patients was discarded.
Not exact matches
«Many of these
methods are already being studied in
clinical trials, but the path from
clinical trials to
routine clinical use is seldom easy,» Mankoff said.
This is intended to verify the efficacy of this treatment
method, and to help ensure the implementation of dTMS for MS - associated fatigue into
routine clinical practice.
In order to test whether the
method is suitable for use in
clinical routine diagnostics, the scientists analyzed more than 1,100 additional tumor samples.
Furthermore, it is an easy
method to perform in the context of veterinary cardiology, which renders it suitable for use in
routine veterinary cardiology along with
clinical, radiographic and echocardiographic evaluations.